SlideShare una empresa de Scribd logo
1 de 16
Descargar para leer sin conexión
Body Mass Index of
Adolescent and Adult Survivors of
Pediatric Acute Lymphoblastic
Leukemia – A Meta-Analysis
Gina Nam, BA, BS
Research Assistant
HuntsmanCancer Institute, Cancer Control and Population Sciences
INTRODUCTION
• Over 60% of adolescent or adult survivors of pediatric cancer
experience at least one late effect in first decade following their
diagnosis.
• Late effects include cardiovascular disease, second cancers, and
alterations in growth and development.
• A possible late effect is the development of an abnormal body
composition (e.g., being overweight or obese) that can potentially
increase the risk of developing other chronic health conditions.
ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
3%
57%
78%
92%
Survival Rates
1964 20091987
• ALL is the most common pediatric
cancer in the U.S.
• About 3,000 children and adolescents
are diagnosed in the U.S. with ALL every
year.
Source:American Childhood Cancer Organization
BODY MASS INDEX (BMI)
Adults Adolescents
Underweight ≤ 18.5 kg/m2 ≤ 5th percentile
Normal 18.5 – 25 kg/m2 5th – 85th percentile
Overweight 25 – 30 kg/m2 85th – 95th percentile
Obese ≥ 30 kg/m2 ≥ 95th percentile
EXISTING LITERATURE
• Existing systematic reviews suggest that during childhood, survivors
of pediatric ALL have higher BMIs than normative populations.
• However, mixed evidence exists on the risk of overweight/obesity
among adolescent and adult survivors of pediatric ALL.
• No meta-analyses on BMI among adolescent and adult survivors of
pediatric ALL.
OBJECTIVES
• Conduct a meta-analysis of studies that investigate the BMI of
adolescent and adult survivors of pediatric ALL.
• Systematically summarize literature.
• Quantify overall effect size and effect sizes for sex differences.
• Critical assessment of existing gaps in literature.
METHODS
Identified Studies
(N=109)
• PRISMA Guidelines.
• Multiple search engines.
• Search phrases: e.g.
ALL, body
composition, BMI, overwe
ight, adiposity etc.
• Time frame: 1994-2014.
InclusionCriteria (N=11)
• ALL diagnosed at <21
years of age.
• Age at study ≥16 years.
• BMI at the end of the
primary therapy phase.
• Comparison sample or
population norms.
• Peer-reviewed.
Coding & Analyses
• Coding into Excel by 2
investigators.
• Cross-checked by 2 other
researchers.
• Reliability analysis in
progress.
• Effect size analysis in Stata
and R.
STUDY EFFECT SIZE
Long-Term BMI Health Outcome in
Adolescents or Adults
Overweight/Obese Normal
ALL Survivors a b
Controls c d
BMI cutoff points for overweight/obese are based on BMI
classification guidelines for adolescents and adults as appropriate.
STUDIES (N=11)
Author Year Location N ALL Survivors N Controls Stratification
Birkebæk et al 1998 Denmark 33 NA Treatment
Garmey et al 2008 U.S. 1,451 2,167 Sex, Treatment
Geenen et al 2010 Netherlands 141 69 Treatment
Jarfelt et al 2005 Sweden 35 5,439 Sex, Treatment
Meacham et al 2005 U.S. 1,665 40,899 Sex
Ness et al 2007 U.S. 75 NA Sex
Oeffinger et al 2003 U.S. 1,765 2,565 Sex, Age, Treatment
Shaw et al 2000 United Kingdom 33 66 Sex
Tylavsky et al 2010 U.S. 164 NA Age
Veringa et al 2012 Netherlands 68 6,555 Sex, Treatment
Warner et al 2013 U.S. 165 5,410 Sex
FOREST PLOT for ODDS RATIO (N=7*)
STUDY OR Plot OR (95% CI) %WEIGHT
*4 studies do not provide enough information to compute OR.
Non U.S. Studies
1.11 (1.04-1.19)
FEMALE SURVIVORS in the U.S. (N=4)
STUDY OR Plot OR (95% CI) %WEIGHT
Overall (I-squared = 74.3%, p = 0.001)
Warner
Oeffinger
Study
Oeffinger
ID
Oeffinger
Garmey
Oeffinger
Meacham
1.32 (1.20, 1.45)
1.14 (0.73, 1.78)
1.29 (0.62, 2.67)
1.76 (1.31, 2.36)
OR (95% CI)
1.67 (1.05, 2.65)
1.72 (1.42, 2.07)
1.32 (0.93, 1.88)
1.04 (0.91, 1.20)
100.00
4.76
1.69
%
9.32
Weight
3.71
22.70
7.26
50.55
1.32 (1.20, 1.45)
1.14 (0.73, 1.78)
1.29 (0.62, 2.67)
1.76 (1.31, 2.36)
OR (95% CI)
1.67 (1.05, 2.65)
1.72 (1.42, 2.07)
1.32 (0.93, 1.88)
1.04 (0.91, 1.20)
100.00
4.76
1.69
%
9.32
Weight
3.71
22.70
7.26
50.55
10 1 3
MALE SURVIVORS in the U.S. (N=4)
STUDY OR Plot OR (95% CI) %WEIGHT
Overall (I-squared = 77.5%, p = 0.000)
Oeffinger
Warner
Oeffinger
Meacham
Oeffinger
ID
Study
Garmey
Oeffinger
0.93 (0.85, 1.03)
1.46 (1.11, 1.92)
1.29 (0.85, 1.95)
0.80 (0.49, 1.29)
0.76 (0.66, 0.87)
2.60 (0.97, 6.97)
OR (95% CI)
1.03 (0.84, 1.26)
0.89 (0.63, 1.26)
100.00
9.99
4.56
4.19
51.90
0.70
Weight
%
20.84
7.82
0.93 (0.85, 1.03)
1.46 (1.11, 1.92)
1.29 (0.85, 1.95)
0.80 (0.49, 1.29)
0.76 (0.66, 0.87)
2.60 (0.97, 6.97)
OR (95% CI)
1.03 (0.84, 1.26)
0.89 (0.63, 1.26)
100.00
9.99
4.56
4.19
51.90
0.70
Weight
%
20.84
7.82
10 1 7
GAPS IN EXISTING LITERATURE
• Identified only 11 quality studies, of which 6 were conducted in the U.S.
• Reporting standards not unique.
• 9 studies report BMI proportions.
• 7 studies report mean BMI.
• 2 studies report BMI Z-score relative to reference values.
• Missing information on a host of important variables.
• Cancer relapse.
• Detailed treatment and BMI.
• Family medical history.
• Sample size of controls.
CONCLUSIONS/RECOMMENDATIONS
• Overall effect size for survivors in the U.S.
• OR= 1.11; 95% CI= 1.04-1.19.
• Female survivors (OR=1.32; 95% CI=1.20-1.45 ) may be overweight/obese at
greater numbers than male survivors (OR=0.93; 95% CI=0.85-1.03).
• Recommendations:
• Long-term health management programs for adolescent and adult survivors
of pediatric ALL.
• More emphasis on addressing weight-related health behaviors for female
survivors of pediatric ALL.
• Standardized reporting of results for robust meta-analyses.
LIMITATIONS
• BMI is an indirect measurement of body fat, and does not reflect
changes in muscle mass or changes that occur with age in adulthood.
• With the limited number of available studies, characteristics of
control population, treatment etc. are inconclusive.
Thank you!
gina.nam@hci.utah.edu
Collaborators:
 Richard Nelson, PhD
 Sapna Kaul, PhD, MA
Yelena Wu, PhD
 Anne Kirchhoff, PhD, MPH
Funded by the Center for Children’s Cancer
Research at the Huntsman Cancer
Institute

Más contenido relacionado

La actualidad más candente

Breast Cancer Prevention with Physical Activity and Exercise
Breast Cancer Prevention with Physical Activity and ExerciseBreast Cancer Prevention with Physical Activity and Exercise
Breast Cancer Prevention with Physical Activity and ExerciseDarryl Edwards
 
PICOT - Post-Menopausal Exercise and Cardiovascular Disease Risk
PICOT - Post-Menopausal Exercise and Cardiovascular Disease RiskPICOT - Post-Menopausal Exercise and Cardiovascular Disease Risk
PICOT - Post-Menopausal Exercise and Cardiovascular Disease RiskJonathanJuca
 
Cancer & Exercise - Summer Research Program
Cancer & Exercise - Summer Research ProgramCancer & Exercise - Summer Research Program
Cancer & Exercise - Summer Research ProgramGlobal Institute GIPPEC
 
Integrated Cancer Prevention
Integrated Cancer Prevention Integrated Cancer Prevention
Integrated Cancer Prevention Lisa Nelson
 
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna CampbellThe Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna CampbellScottish Cancer Prevention Network
 
Lapband Seminar PORT LAPSURGERY
Lapband Seminar PORT LAPSURGERYLapband Seminar PORT LAPSURGERY
Lapband Seminar PORT LAPSURGERYguestc242dc
 
Report Back from San Antonio Breast Cancer Symposium: Spotlight on MBC
Report Back from San Antonio Breast Cancer Symposium: Spotlight on MBCReport Back from San Antonio Breast Cancer Symposium: Spotlight on MBC
Report Back from San Antonio Breast Cancer Symposium: Spotlight on MBCbkling
 
Lapband Seminar Port Lap Surgery
Lapband Seminar Port Lap SurgeryLapband Seminar Port Lap Surgery
Lapband Seminar Port Lap Surgeryportlapsurgery
 
The Link Between Breast Cancer and Hormones_ Kristin Rojas MD
The Link Between Breast Cancer and Hormones_ Kristin Rojas MDThe Link Between Breast Cancer and Hormones_ Kristin Rojas MD
The Link Between Breast Cancer and Hormones_ Kristin Rojas MDKristinRojas1
 
Nonalcoholic fatty liver disease and carotid atherosclerosis in children
Nonalcoholic fatty liver disease and carotid atherosclerosis in childrenNonalcoholic fatty liver disease and carotid atherosclerosis in children
Nonalcoholic fatty liver disease and carotid atherosclerosis in childrenSHAPE Society
 
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer RecurrenceIntermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrencebkling
 
New Treatment Options for Uterine Cancer
New Treatment Options for Uterine CancerNew Treatment Options for Uterine Cancer
New Treatment Options for Uterine Cancerbkling
 
HCS 420 Final Paper- Breast Cancer
HCS 420 Final Paper- Breast CancerHCS 420 Final Paper- Breast Cancer
HCS 420 Final Paper- Breast CancerMegan Serafin
 

La actualidad más candente (18)

Breast Cancer Prevention with Physical Activity and Exercise
Breast Cancer Prevention with Physical Activity and ExerciseBreast Cancer Prevention with Physical Activity and Exercise
Breast Cancer Prevention with Physical Activity and Exercise
 
PICOT - Post-Menopausal Exercise and Cardiovascular Disease Risk
PICOT - Post-Menopausal Exercise and Cardiovascular Disease RiskPICOT - Post-Menopausal Exercise and Cardiovascular Disease Risk
PICOT - Post-Menopausal Exercise and Cardiovascular Disease Risk
 
Cancer & Exercise - Summer Research Program
Cancer & Exercise - Summer Research ProgramCancer & Exercise - Summer Research Program
Cancer & Exercise - Summer Research Program
 
The Changing Relationship Between Obesity and Disability 4.14.08
The Changing Relationship Between Obesity and Disability 4.14.08The Changing Relationship Between Obesity and Disability 4.14.08
The Changing Relationship Between Obesity and Disability 4.14.08
 
Integrated Cancer Prevention
Integrated Cancer Prevention Integrated Cancer Prevention
Integrated Cancer Prevention
 
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna CampbellThe Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
 
Lapband Seminar PORT LAPSURGERY
Lapband Seminar PORT LAPSURGERYLapband Seminar PORT LAPSURGERY
Lapband Seminar PORT LAPSURGERY
 
MetSyn_Poster.Final
MetSyn_Poster.FinalMetSyn_Poster.Final
MetSyn_Poster.Final
 
Fighting Cancer With Your Fork
Fighting Cancer With Your ForkFighting Cancer With Your Fork
Fighting Cancer With Your Fork
 
Report Back from San Antonio Breast Cancer Symposium: Spotlight on MBC
Report Back from San Antonio Breast Cancer Symposium: Spotlight on MBCReport Back from San Antonio Breast Cancer Symposium: Spotlight on MBC
Report Back from San Antonio Breast Cancer Symposium: Spotlight on MBC
 
Lapband Seminar Port Lap Surgery
Lapband Seminar Port Lap SurgeryLapband Seminar Port Lap Surgery
Lapband Seminar Port Lap Surgery
 
The Link Between Breast Cancer and Hormones_ Kristin Rojas MD
The Link Between Breast Cancer and Hormones_ Kristin Rojas MDThe Link Between Breast Cancer and Hormones_ Kristin Rojas MD
The Link Between Breast Cancer and Hormones_ Kristin Rojas MD
 
Nonalcoholic fatty liver disease and carotid atherosclerosis in children
Nonalcoholic fatty liver disease and carotid atherosclerosis in childrenNonalcoholic fatty liver disease and carotid atherosclerosis in children
Nonalcoholic fatty liver disease and carotid atherosclerosis in children
 
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer RecurrenceIntermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
 
New Treatment Options for Uterine Cancer
New Treatment Options for Uterine CancerNew Treatment Options for Uterine Cancer
New Treatment Options for Uterine Cancer
 
Body composition technology
Body composition technologyBody composition technology
Body composition technology
 
Micro-albuminuria in non-diabetic, non-hypertensive cardiovascular disease (C...
Micro-albuminuria in non-diabetic, non-hypertensive cardiovascular disease (C...Micro-albuminuria in non-diabetic, non-hypertensive cardiovascular disease (C...
Micro-albuminuria in non-diabetic, non-hypertensive cardiovascular disease (C...
 
HCS 420 Final Paper- Breast Cancer
HCS 420 Final Paper- Breast CancerHCS 420 Final Paper- Breast Cancer
HCS 420 Final Paper- Breast Cancer
 

Similar a Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphoblastic Leukemia – A Meta-Analysis

Age Bias in Cancer Care
Age Bias in Cancer CareAge Bias in Cancer Care
Age Bias in Cancer Carebkling
 
Ethnic differences, obesity and cancer, stages of the obesity epidemic and ca...
Ethnic differences, obesity and cancer, stages of the obesity epidemic and ca...Ethnic differences, obesity and cancer, stages of the obesity epidemic and ca...
Ethnic differences, obesity and cancer, stages of the obesity epidemic and ca...World Cancer Research Fund International
 
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...Marmara University School of Medicine
 
Cancer Survivorship Challenges and Opportunities
Cancer Survivorship Challenges and OpportunitiesCancer Survivorship Challenges and Opportunities
Cancer Survivorship Challenges and OpportunitiesGaynorOncology
 
October 2018 Webinar | Older Adults and Colorectal Cancer
October 2018 Webinar | Older Adults and Colorectal CancerOctober 2018 Webinar | Older Adults and Colorectal Cancer
October 2018 Webinar | Older Adults and Colorectal CancerFight Colorectal Cancer
 
Lifestyle medicine and cancer 2012
Lifestyle medicine and cancer 2012Lifestyle medicine and cancer 2012
Lifestyle medicine and cancer 2012EsserHealth
 
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...ueda2015
 
RESEARCHDOC HSR POSTER
RESEARCHDOC HSR POSTERRESEARCHDOC HSR POSTER
RESEARCHDOC HSR POSTERKelly Huynh
 
Evidence based medicine and cosmetic surgery
Evidence based medicine and cosmetic surgeryEvidence based medicine and cosmetic surgery
Evidence based medicine and cosmetic surgerydrmoradisyd
 
Evidence based-medicine-and-cosmetic-surgery
Evidence based-medicine-and-cosmetic-surgeryEvidence based-medicine-and-cosmetic-surgery
Evidence based-medicine-and-cosmetic-surgerydrpouriamoradi
 
Nutritional status and effect of exercise in young women
Nutritional status and effect of exercise in young womenNutritional status and effect of exercise in young women
Nutritional status and effect of exercise in young womenDr. BMN college of Home Science
 
Adolescent poly cystic ovary (PCO)
Adolescent poly cystic ovary (PCO)Adolescent poly cystic ovary (PCO)
Adolescent poly cystic ovary (PCO)Wael Mohamed
 
obesity by Dr.subhash dwivedi ,BHMS FINAL YEAR STUDENTS
obesity by Dr.subhash dwivedi ,BHMS FINAL YEAR STUDENTSobesity by Dr.subhash dwivedi ,BHMS FINAL YEAR STUDENTS
obesity by Dr.subhash dwivedi ,BHMS FINAL YEAR STUDENTSrajusingh345685
 
2016 ESMO Asia - Prognostic factors among ER+HER2- breast cancer patients
2016 ESMO Asia - Prognostic factors among ER+HER2- breast cancer patients2016 ESMO Asia - Prognostic factors among ER+HER2- breast cancer patients
2016 ESMO Asia - Prognostic factors among ER+HER2- breast cancer patientsYvonne Lee
 
Association between Body Mass Index and Severity According of Classification ...
Association between Body Mass Index and Severity According of Classification ...Association between Body Mass Index and Severity According of Classification ...
Association between Body Mass Index and Severity According of Classification ...JohnJulie1
 

Similar a Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphoblastic Leukemia – A Meta-Analysis (20)

Age Bias in Cancer Care
Age Bias in Cancer CareAge Bias in Cancer Care
Age Bias in Cancer Care
 
The Continuous Update Project | Prof. Martin Wiseman
The Continuous Update Project | Prof. Martin WisemanThe Continuous Update Project | Prof. Martin Wiseman
The Continuous Update Project | Prof. Martin Wiseman
 
POCPA9_2013_v14n11_7023-3
POCPA9_2013_v14n11_7023-3POCPA9_2013_v14n11_7023-3
POCPA9_2013_v14n11_7023-3
 
diabetesisamatteroffat
diabetesisamatteroffatdiabetesisamatteroffat
diabetesisamatteroffat
 
Ethnic differences, obesity and cancer, stages of the obesity epidemic and ca...
Ethnic differences, obesity and cancer, stages of the obesity epidemic and ca...Ethnic differences, obesity and cancer, stages of the obesity epidemic and ca...
Ethnic differences, obesity and cancer, stages of the obesity epidemic and ca...
 
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
Q and A's - Breast Cancer Survivors and Menopausal symptoms- Hormonal and non...
 
Cancer Survivorship Challenges and Opportunities
Cancer Survivorship Challenges and OpportunitiesCancer Survivorship Challenges and Opportunities
Cancer Survivorship Challenges and Opportunities
 
October 2018 Webinar | Older Adults and Colorectal Cancer
October 2018 Webinar | Older Adults and Colorectal CancerOctober 2018 Webinar | Older Adults and Colorectal Cancer
October 2018 Webinar | Older Adults and Colorectal Cancer
 
Lifestyle medicine and cancer 2012
Lifestyle medicine and cancer 2012Lifestyle medicine and cancer 2012
Lifestyle medicine and cancer 2012
 
Prevalence of obesity
Prevalence of obesity Prevalence of obesity
Prevalence of obesity
 
Mc Tiernan - 20th International Nutrition Congress 2013
Mc Tiernan - 20th International Nutrition Congress 2013Mc Tiernan - 20th International Nutrition Congress 2013
Mc Tiernan - 20th International Nutrition Congress 2013
 
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
 
RESEARCHDOC HSR POSTER
RESEARCHDOC HSR POSTERRESEARCHDOC HSR POSTER
RESEARCHDOC HSR POSTER
 
Evidence based medicine and cosmetic surgery
Evidence based medicine and cosmetic surgeryEvidence based medicine and cosmetic surgery
Evidence based medicine and cosmetic surgery
 
Evidence based-medicine-and-cosmetic-surgery
Evidence based-medicine-and-cosmetic-surgeryEvidence based-medicine-and-cosmetic-surgery
Evidence based-medicine-and-cosmetic-surgery
 
Nutritional status and effect of exercise in young women
Nutritional status and effect of exercise in young womenNutritional status and effect of exercise in young women
Nutritional status and effect of exercise in young women
 
Adolescent poly cystic ovary (PCO)
Adolescent poly cystic ovary (PCO)Adolescent poly cystic ovary (PCO)
Adolescent poly cystic ovary (PCO)
 
obesity by Dr.subhash dwivedi ,BHMS FINAL YEAR STUDENTS
obesity by Dr.subhash dwivedi ,BHMS FINAL YEAR STUDENTSobesity by Dr.subhash dwivedi ,BHMS FINAL YEAR STUDENTS
obesity by Dr.subhash dwivedi ,BHMS FINAL YEAR STUDENTS
 
2016 ESMO Asia - Prognostic factors among ER+HER2- breast cancer patients
2016 ESMO Asia - Prognostic factors among ER+HER2- breast cancer patients2016 ESMO Asia - Prognostic factors among ER+HER2- breast cancer patients
2016 ESMO Asia - Prognostic factors among ER+HER2- breast cancer patients
 
Association between Body Mass Index and Severity According of Classification ...
Association between Body Mass Index and Severity According of Classification ...Association between Body Mass Index and Severity According of Classification ...
Association between Body Mass Index and Severity According of Classification ...
 

Más de dylanturner22

Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life AssessmentRobust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessmentdylanturner22
 
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...dylanturner22
 
Intermountain Diabetes Prevention Program:
Intermountain Diabetes Prevention Program:Intermountain Diabetes Prevention Program:
Intermountain Diabetes Prevention Program:dylanturner22
 
The University of Utah Center for Clinical and Translational Science (CCTS)
The University of Utah Center for Clinical and Translational Science (CCTS)The University of Utah Center for Clinical and Translational Science (CCTS)
The University of Utah Center for Clinical and Translational Science (CCTS)dylanturner22
 
Psychological Foundation of Clinical Decision-Support
Psychological Foundation of Clinical Decision-SupportPsychological Foundation of Clinical Decision-Support
Psychological Foundation of Clinical Decision-Supportdylanturner22
 
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...dylanturner22
 
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...dylanturner22
 
Pros In Clinical Care
Pros In Clinical CarePros In Clinical Care
Pros In Clinical Caredylanturner22
 
Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related  Quality-of-life AssessmentRobust Methods for Health-related  Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessmentdylanturner22
 
Agreement between Claims-based and Self-reported Adherence Measures in Patien...
Agreement between Claims-based and Self-reported Adherence Measures in Patien...Agreement between Claims-based and Self-reported Adherence Measures in Patien...
Agreement between Claims-based and Self-reported Adherence Measures in Patien...dylanturner22
 
Associations of the timing of physical therapy utilization and subsequent he...
Associations of the timing of physical  therapy utilization and subsequent he...Associations of the timing of physical  therapy utilization and subsequent he...
Associations of the timing of physical therapy utilization and subsequent he...dylanturner22
 
The Medicaid and CHIP Payment and Access Commission (MACPAC)
The Medicaid and CHIP Payment and Access Commission (MACPAC)The Medicaid and CHIP Payment and Access Commission (MACPAC)
The Medicaid and CHIP Payment and Access Commission (MACPAC)dylanturner22
 
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIATREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIAdylanturner22
 
The Computerized Symptom Capture Tool (C-SCAT)
The Computerized Symptom Capture Tool (C-SCAT)The Computerized Symptom Capture Tool (C-SCAT)
The Computerized Symptom Capture Tool (C-SCAT)dylanturner22
 
Low 3-dose completion and missed opportunities for the HPV vaccine in Utah
Low 3-dose completion and missed opportunities for the HPV vaccine in UtahLow 3-dose completion and missed opportunities for the HPV vaccine in Utah
Low 3-dose completion and missed opportunities for the HPV vaccine in Utahdylanturner22
 
Financial Burden of Pediatric Cancer for Patients and their Families
Financial Burden of Pediatric Cancer for Patients and their FamiliesFinancial Burden of Pediatric Cancer for Patients and their Families
Financial Burden of Pediatric Cancer for Patients and their Familiesdylanturner22
 

Más de dylanturner22 (16)

Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life AssessmentRobust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessment
 
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
 
Intermountain Diabetes Prevention Program:
Intermountain Diabetes Prevention Program:Intermountain Diabetes Prevention Program:
Intermountain Diabetes Prevention Program:
 
The University of Utah Center for Clinical and Translational Science (CCTS)
The University of Utah Center for Clinical and Translational Science (CCTS)The University of Utah Center for Clinical and Translational Science (CCTS)
The University of Utah Center for Clinical and Translational Science (CCTS)
 
Psychological Foundation of Clinical Decision-Support
Psychological Foundation of Clinical Decision-SupportPsychological Foundation of Clinical Decision-Support
Psychological Foundation of Clinical Decision-Support
 
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
 
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
 
Pros In Clinical Care
Pros In Clinical CarePros In Clinical Care
Pros In Clinical Care
 
Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related  Quality-of-life AssessmentRobust Methods for Health-related  Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessment
 
Agreement between Claims-based and Self-reported Adherence Measures in Patien...
Agreement between Claims-based and Self-reported Adherence Measures in Patien...Agreement between Claims-based and Self-reported Adherence Measures in Patien...
Agreement between Claims-based and Self-reported Adherence Measures in Patien...
 
Associations of the timing of physical therapy utilization and subsequent he...
Associations of the timing of physical  therapy utilization and subsequent he...Associations of the timing of physical  therapy utilization and subsequent he...
Associations of the timing of physical therapy utilization and subsequent he...
 
The Medicaid and CHIP Payment and Access Commission (MACPAC)
The Medicaid and CHIP Payment and Access Commission (MACPAC)The Medicaid and CHIP Payment and Access Commission (MACPAC)
The Medicaid and CHIP Payment and Access Commission (MACPAC)
 
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIATREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
 
The Computerized Symptom Capture Tool (C-SCAT)
The Computerized Symptom Capture Tool (C-SCAT)The Computerized Symptom Capture Tool (C-SCAT)
The Computerized Symptom Capture Tool (C-SCAT)
 
Low 3-dose completion and missed opportunities for the HPV vaccine in Utah
Low 3-dose completion and missed opportunities for the HPV vaccine in UtahLow 3-dose completion and missed opportunities for the HPV vaccine in Utah
Low 3-dose completion and missed opportunities for the HPV vaccine in Utah
 
Financial Burden of Pediatric Cancer for Patients and their Families
Financial Burden of Pediatric Cancer for Patients and their FamiliesFinancial Burden of Pediatric Cancer for Patients and their Families
Financial Burden of Pediatric Cancer for Patients and their Families
 

Último

Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 

Último (20)

Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 

Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphoblastic Leukemia – A Meta-Analysis

  • 1. Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphoblastic Leukemia – A Meta-Analysis Gina Nam, BA, BS Research Assistant HuntsmanCancer Institute, Cancer Control and Population Sciences
  • 2. INTRODUCTION • Over 60% of adolescent or adult survivors of pediatric cancer experience at least one late effect in first decade following their diagnosis. • Late effects include cardiovascular disease, second cancers, and alterations in growth and development. • A possible late effect is the development of an abnormal body composition (e.g., being overweight or obese) that can potentially increase the risk of developing other chronic health conditions.
  • 3. ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 3% 57% 78% 92% Survival Rates 1964 20091987 • ALL is the most common pediatric cancer in the U.S. • About 3,000 children and adolescents are diagnosed in the U.S. with ALL every year. Source:American Childhood Cancer Organization
  • 4. BODY MASS INDEX (BMI) Adults Adolescents Underweight ≤ 18.5 kg/m2 ≤ 5th percentile Normal 18.5 – 25 kg/m2 5th – 85th percentile Overweight 25 – 30 kg/m2 85th – 95th percentile Obese ≥ 30 kg/m2 ≥ 95th percentile
  • 5. EXISTING LITERATURE • Existing systematic reviews suggest that during childhood, survivors of pediatric ALL have higher BMIs than normative populations. • However, mixed evidence exists on the risk of overweight/obesity among adolescent and adult survivors of pediatric ALL. • No meta-analyses on BMI among adolescent and adult survivors of pediatric ALL.
  • 6. OBJECTIVES • Conduct a meta-analysis of studies that investigate the BMI of adolescent and adult survivors of pediatric ALL. • Systematically summarize literature. • Quantify overall effect size and effect sizes for sex differences. • Critical assessment of existing gaps in literature.
  • 7. METHODS Identified Studies (N=109) • PRISMA Guidelines. • Multiple search engines. • Search phrases: e.g. ALL, body composition, BMI, overwe ight, adiposity etc. • Time frame: 1994-2014. InclusionCriteria (N=11) • ALL diagnosed at <21 years of age. • Age at study ≥16 years. • BMI at the end of the primary therapy phase. • Comparison sample or population norms. • Peer-reviewed. Coding & Analyses • Coding into Excel by 2 investigators. • Cross-checked by 2 other researchers. • Reliability analysis in progress. • Effect size analysis in Stata and R.
  • 8. STUDY EFFECT SIZE Long-Term BMI Health Outcome in Adolescents or Adults Overweight/Obese Normal ALL Survivors a b Controls c d BMI cutoff points for overweight/obese are based on BMI classification guidelines for adolescents and adults as appropriate.
  • 9. STUDIES (N=11) Author Year Location N ALL Survivors N Controls Stratification Birkebæk et al 1998 Denmark 33 NA Treatment Garmey et al 2008 U.S. 1,451 2,167 Sex, Treatment Geenen et al 2010 Netherlands 141 69 Treatment Jarfelt et al 2005 Sweden 35 5,439 Sex, Treatment Meacham et al 2005 U.S. 1,665 40,899 Sex Ness et al 2007 U.S. 75 NA Sex Oeffinger et al 2003 U.S. 1,765 2,565 Sex, Age, Treatment Shaw et al 2000 United Kingdom 33 66 Sex Tylavsky et al 2010 U.S. 164 NA Age Veringa et al 2012 Netherlands 68 6,555 Sex, Treatment Warner et al 2013 U.S. 165 5,410 Sex
  • 10. FOREST PLOT for ODDS RATIO (N=7*) STUDY OR Plot OR (95% CI) %WEIGHT *4 studies do not provide enough information to compute OR. Non U.S. Studies 1.11 (1.04-1.19)
  • 11. FEMALE SURVIVORS in the U.S. (N=4) STUDY OR Plot OR (95% CI) %WEIGHT Overall (I-squared = 74.3%, p = 0.001) Warner Oeffinger Study Oeffinger ID Oeffinger Garmey Oeffinger Meacham 1.32 (1.20, 1.45) 1.14 (0.73, 1.78) 1.29 (0.62, 2.67) 1.76 (1.31, 2.36) OR (95% CI) 1.67 (1.05, 2.65) 1.72 (1.42, 2.07) 1.32 (0.93, 1.88) 1.04 (0.91, 1.20) 100.00 4.76 1.69 % 9.32 Weight 3.71 22.70 7.26 50.55 1.32 (1.20, 1.45) 1.14 (0.73, 1.78) 1.29 (0.62, 2.67) 1.76 (1.31, 2.36) OR (95% CI) 1.67 (1.05, 2.65) 1.72 (1.42, 2.07) 1.32 (0.93, 1.88) 1.04 (0.91, 1.20) 100.00 4.76 1.69 % 9.32 Weight 3.71 22.70 7.26 50.55 10 1 3
  • 12. MALE SURVIVORS in the U.S. (N=4) STUDY OR Plot OR (95% CI) %WEIGHT Overall (I-squared = 77.5%, p = 0.000) Oeffinger Warner Oeffinger Meacham Oeffinger ID Study Garmey Oeffinger 0.93 (0.85, 1.03) 1.46 (1.11, 1.92) 1.29 (0.85, 1.95) 0.80 (0.49, 1.29) 0.76 (0.66, 0.87) 2.60 (0.97, 6.97) OR (95% CI) 1.03 (0.84, 1.26) 0.89 (0.63, 1.26) 100.00 9.99 4.56 4.19 51.90 0.70 Weight % 20.84 7.82 0.93 (0.85, 1.03) 1.46 (1.11, 1.92) 1.29 (0.85, 1.95) 0.80 (0.49, 1.29) 0.76 (0.66, 0.87) 2.60 (0.97, 6.97) OR (95% CI) 1.03 (0.84, 1.26) 0.89 (0.63, 1.26) 100.00 9.99 4.56 4.19 51.90 0.70 Weight % 20.84 7.82 10 1 7
  • 13. GAPS IN EXISTING LITERATURE • Identified only 11 quality studies, of which 6 were conducted in the U.S. • Reporting standards not unique. • 9 studies report BMI proportions. • 7 studies report mean BMI. • 2 studies report BMI Z-score relative to reference values. • Missing information on a host of important variables. • Cancer relapse. • Detailed treatment and BMI. • Family medical history. • Sample size of controls.
  • 14. CONCLUSIONS/RECOMMENDATIONS • Overall effect size for survivors in the U.S. • OR= 1.11; 95% CI= 1.04-1.19. • Female survivors (OR=1.32; 95% CI=1.20-1.45 ) may be overweight/obese at greater numbers than male survivors (OR=0.93; 95% CI=0.85-1.03). • Recommendations: • Long-term health management programs for adolescent and adult survivors of pediatric ALL. • More emphasis on addressing weight-related health behaviors for female survivors of pediatric ALL. • Standardized reporting of results for robust meta-analyses.
  • 15. LIMITATIONS • BMI is an indirect measurement of body fat, and does not reflect changes in muscle mass or changes that occur with age in adulthood. • With the limited number of available studies, characteristics of control population, treatment etc. are inconclusive.
  • 16. Thank you! gina.nam@hci.utah.edu Collaborators:  Richard Nelson, PhD  Sapna Kaul, PhD, MA Yelena Wu, PhD  Anne Kirchhoff, PhD, MPH Funded by the Center for Children’s Cancer Research at the Huntsman Cancer Institute

Notas del editor

  1. Cancer has been and still is the leading cause of death in the US. However, survival rates have increased for past decades and over 60% of adolescent or adult survivors of ped cancer experience at least one late effect such as cadiovascular disease, secondary cancers, and developing abnormal body composition that can further increase the risk of developing other chronic health conditions.
  2. Our study focused on Pediatric Acute Lymphoblastic Leukemia, or ALL, because it is the most common childhood cancer diagnosis in the US. It accounts for about 30% of childhood cancer diagnosis, and about 3,000 children and adolescents are diagnosed in the US with ALL every year. With the improvement of treatment, survival rate today has been improved from 3% to 90%, meaning that many survive well into adulthood when late-effects become an issue.
  3. To examine abnormal body composition as a possible late effect in ALL survivors such as overweight and obesity, BMI is the most simple and easy way to screen for possible weight issues, and also a reliable indicator of body fatness for most people. It is calculated by dividing weight by height. Even though BMI is measured in the same way, BMI of adults and adolescents are interpreted using different guidelines. And the studies we looked at followed guidelines accordingly.
  4. There are a few meta-analytic reviews available suggesting that children survivors of pediatric ALL have higher BMIs than age-matched comparison populations. However, we do not have a conclusive evidence on the risk of overweight/obesity among adolescent and adult survivors of pediatric ALL as a long term late-effect. And no meta-analyses on these age groups either.
  5. So, our study conduct a meta-anlaysis of studies that investigate the BMI of adolescent and adult survivors of pediatric ALL to systematically summarize existing literature, quantify overall effect size as well as effect sizes for sex differences, because women tend to have a higher BMIs than men in general population, and finally critical assess gaps in literature.
  6. We initially identified 109 studies using PRISMA guidelines. We used Google Scholary, Embase, PubMed and other search engines with search phrases including ALL with terms related to change in body composition, such as body mass index, overweight, obesity, adiposity and so on.Then, we further distilled studies specific to our topic by using these following inclusion criteria, which gave us total of 11 studies for us to code and analyze. Coding is primarily done by 2 investigators with cross-check by 2 others. And we have a preliminary results, where we looked at effect sizes using Stata and R. We are currently checking reliability of the data.
  7. So our primary effect size wasodds ratio of a prevalence of overweight/obesity, as one combined category, of ALL survivors compared to control groups with 95% Confidence Interval. And the proportion of overweight/obese are categorized based on BMI classification guidelines accordingly.
  8. These are the studies we identified. And as you can see, the location, number of subjects, and stratification are vary. Also, quite a few does not report the total sample size of control groups. 6 US Studies8 Studies stratified by Sex6 Studies stratified by Therapy4 Studies that have mixed age group of adolescent and adult survivors.
  9. Here is the forest plot for all studies that provided odds ratios where you can see it visually and numerically. So there were7 studies out of 11 studies provided enough information for us to compute OR. Some have multiple outcomes because of a stratification (either based on sex or age). Of 7 studies, 3 were non U.S. studies and they were either too low or too high. Weighted Overall odds ratio was 1.13, meaning ALL survivors are 13% more prone to develop overweight/obese than controls.
  10. Because women tend to achieve higher BMI than men in general population, we looked at female and male survivors of pediatric ALL separately. As the European studies appeared to be outliers, we only included the U.S. studies. Also, there are multiple outcomes for Oeffinger, because they were stratified by not only sex, but also age group as well. So when we looked at female only, all of the studies had odds ratio over 1, and the weighted overall OR was 1.32. Meaning female adolescent and adult survivors have a higher prevalence of obesity/obese than controls by 32 %.
  11. For male survivors, we have a mixed results. 3 studies had OR lower than 1, and the other had IR higher than 1. As for overall OR, it was 0.93 which is actually a reverse of what we anticipated.
  12. Within the studies we looked at, there were a few gaps that we would like to discuss. Among 11 studies that we examined, there were only 6 conducted in the US and 3 used Childhood Cancer Survivor Study data, which can overlap the results. Also, BMI outcome measurements in each study were vary from BMI proportions, mean BMI to BMI z-score relative to reference values. Finally, there were missing information that may be crucial to look at such as relapse among ALL survivors that are known to have a risk of even higher BMI, family medical history that can be associated with change in BMI such as down syndrome, diabetes, and growth hormone deficiency, and sample size of control groups.
  13. By looking at 4 studies in the US that provided OR, overall odds ratio was 1.11 with 95% confidence interval of 1.04-1.19. Similar to female children survivors of ALL, female adolescent and adult survivors are more likely to develop overweight/obesity than male survivors. Looking into a prevalence of overweight/obese in adolescent and adult survivors of pediatric ALL, we have a few suggestions for future studies. As our preliminary result shows abnormal body composition in ALL survivors, long-term health management programs for those survivors is highly recommended, especially for female survivors. Also, standardized reporting of results will be helpful for more robust meta-analyses in the future.
  14. We also had a few limitations to consider. BMI is a commonly used too to screen a possible weight issues, but it does not reflect changes in muscle mass or changes that occur with age in adulthood. There are other studies that used xxx to measure body fat accurately, but the number is very limited at the moment. We found that the we don’t fully understand a prevalence of overweight and obesity among adolescent and adult survivors of pediatric ALL despite the fact that abnormal weight change is commonly known as a late-effect in this population. And so it was not challenging to look at other factors that could cause overweight/obese in ALL survivors.
  15. Any questions?Therapy changes